Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind randomised, placebo-controlled trial

Ovchinsky, Nadia; Aumar, Madeleine; Baker, Alastair; Baumann, Ulrich; Butler, Philip; Cananzi, Mara; Czubkowski, Piotr; Durmaz, Oezlem; Fischer, Ryan; Indolfi, Giuseppe; Karnsakul, Wikrom W.; Lacaille, Florence; Lee, Way S.; Maggiore, Giuseppe; Rosenthal, Philip; Ruiz, Mathias; Sokal, Etienne; Sturm, Ekkehard; Woerd, Wendy van der; Verkade, Henkjan J.; Wehrman, Andrew; Clemson, Christine; Yu, Qifeng; Ni, Quanhong; Ruvido, Jessica; Manganaro, Susan; Mattsson, Jan P.

Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind randomised, placebo-controlled trial

Autor(en):

Ovchinsky, Nadia; Aumar, Madeleine; Baker, Alastair; Baumann, Ulrich; Butler, Philip; Cananzi, Mara; Czubkowski, Piotr; Durmaz, Oezlem; Fischer, Ryan; Indolfi, Giuseppe; Karnsakul, Wikrom W.; Lacaille, Florence; Lee, Way S.; Maggiore, Giuseppe; Rosenthal, Philip; Ruiz, Mathias; Sokal, Etienne; Sturm, Ekkehard; Woerd, Wendy van der; Verkade, Henkjan J.; Wehrman, Andrew; Clemson, Christine; Yu, Qifeng; Ni, Quanhong; Ruvido, Jessica; Manganaro, Susan; Mattsson, Jan P.

Tübinger Autor(en):

Sturm, Ekkehard

Erschienen in:

Lancet Gastroenterology & Hepatology (2024), Bd. 9, H. 7, S. 632-645

Verlagsangabe:

San Diego : Elsevier Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S2468-1253(24)00074-8

ISSN:

2468-1253